Clinical Trials Sponsored by Albert Ellis Institute, New York

Total 984 results

New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil

HIV Infections | HIV Infection

Brazil
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); Washington University School of... and other collaborators

Recruiting

OnTrackNY's Learning Healthcare System

First Episode Psychosis

United States
New York Stem Cell Foundation Research Institute
Stevens Institute of Technology

Recruiting

Personalized Models for Cancer Research

Solid Tumor, Adult

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Not yet recruiting

Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

Inflammation | Family Relations | HPA | CBCL

United States, Brazil
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Recruiting

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial (REVISIT-C)

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Recruiting

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Cocaine Use Disorder

United States
New York State Psychiatric Institute
Bayer; National Institute on Aging (NIA)

Completed

Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172

Late Onset Alzheimer Disease

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder

Borderline Personality Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Overlapping Neural Circuits in Pediatric OCD

Obsessive Compulsive Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

Pain | Cannabis | Hyperalgesia | Tolerance

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Influence of Tobacco Use on Cannabis Use

Tobacco Use | Cannabis Use

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Suspended

Glutamatergic Mechanisms: Aim2

Healthy

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Active, not recruiting

IM Ketamine vs Midazolam for Suicidal ER Patients

Suicidal Ideation | Depression, Unipolar | Depression, Bipolar

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3

Substance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

Cannabis Use

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

Nabilone in Cannabis Users With PTSD

Cannabis | Post Traumatic Stress Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Sequenced Behavioral and Medication Intervention for Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients

Cannabis Use Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

Major Depressive Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Facilitating the Behavioral Treatment of Cannabis Use Disorder

Cannabis Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (Vyvance)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients

Benzodiazepine Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (TACT2)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1

ADHD | Opioid-Related Disorders | Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder

Marijuana Abuse | Attention Deficit Disorder With Hyperactivity

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

The Cultural Formulation Interview-Engagement Aid (CFI-EA)

Communication | Adherence, Patient

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Clinical Trial of AVL-3288 in Schizophrenia Patients

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Medication-Assisted Treatment for Youth With Substance Use Disorders

Opioid Use Disorder | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Pomaglumetad Effects on Glutamate Biomarkers

Healthy Controls

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Naltrexone Treatment for Opioid Dependence (Domino)

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1

Tobacco Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3

Tobacco Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Improved Strategies for Outpatient Opioid Detoxification

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1

Alcoholism | Gambling
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effects of Aripiprazole on Cocaine Craving and Self-Administration

Cocaine Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Prescription Opioid Effects in Abusers Versus Non-Abusers

Substance-Related Disorders | Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Laboratory Model for Heroin Abuse Medications - 8

Substance-Related Disorders | Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Baclofen on Marijuana Withdrawal and Relapse

Marijuana Dependence

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Cognitive Skills Training for Homeless Youth

Anxiety Disorders | Substance Abuse | Attention Deficit Disorder | Affective Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Cognitive-Motivational Behavior Therapy for Pathological Gamblers

Pathological Gambling

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Cocaine Abuse and ADHD - 10

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Risperidone Treatment in Dually-Diagnosed Individuals - 2

Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)

Obsessive-Compulsive Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (AV411)

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health Disorder

Pregnancy | HIV | Sexually Transmitted Infection

Brazil
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Terminated

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations

Schizophrenia

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Antidepressant Treatment of Melancholia in Late Life

Depression | Melancholia

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)

Depression | Mood Disorders | Seasonal Affective Disorder

United States

Clinical Trials Sponsored by Albert Ellis Institute, New York

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations